Based on recent data, Caris Life Sciences, Inc. (CAI) shows an Average True Range (ATR) of 1.28 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 2.38M, indicating liquidity. These fundamental metrics provide insight into CAI's underlying financial health and market activity.
| ATR | 1.28 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 2.38M |
| Avg Vol (10 Days) | 1.48M |
Caris Life Sciences, Inc. (CAI) technical indicators as of April 29, 2026: the SMA 20 is -9%, SMA 50 at -22.14%, and SMA 200 at -32.53%. The RSI 14 value is 34.48, suggesting its current momentum. These technical analysis signals help assess CAI's price trends and potential future movements.
| SMA 20 | -9% |
| SMA 50 | -22.14% |
| SMA 200 | -32.53% |
| RSI 14 | 34.48 |
Caris Life Sciences, Inc. (CAI) stock performance overview as of April 29, 2026: The 52-week high is $42.5 (currently -54.73% below), and the 52-week low is $16.28 (currently 12.19% above). Over the past year, CAI's performance is N/A, compared to the S&P 500's 18.77% change.
| 52-Week High | 42.5 |
| 52-Week High Chg | -54.73% |
| 52-Week Low | 16.28 |
| 52-Week Low Chg | +12.19% |
| S&P 500 52-Week Chg | 18.77% |
According to market data, Caris Life Sciences, Inc. (CAI) stock's recent performance metrics show that over the last month, CAI is -3.38%, with a Year-to-Date (YTD) performance of -2.63%. Over the past year, the stock has seen a N/A change. These figures summarize CAI's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 22.16 | 22.16 | 26.96 | 33.13 | 42.5 | 29.32 |
| Low | 18.39 | 16.28 | 16.28 | 16.28 | 16.28 | 16.28 |
| Performance | +2.62% | -3.38% | -16.60% | -7.14% | - | -2.63% |
According to current financial data, CAI stock's P/E (TTM) ratio is -456.81, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for CAI, including P/S (6.47), P/B (53.88), and P/FCF (159.93), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | CAI | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -456.81 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | 6.47 | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 53.88 | 0.25 | 1.15 | 4.72 |
| P/FCF (TTM) | 159.93 | 298.84 | -452.92 | 32.78 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep